【2026年6月改定】知らないと年間4万円の損！心臓の薬はジェネリックで大丈夫？循環器専門医が徹底比較【選定療養費】

⚠️ Starting June 2026, the out-of-pocket cost for "selective medical treatment" will double. If you are currently taking brand-name medication, please check this immediately. Continuing to take brand-name heart medication (e.g., Xareldel) could result in an additional monthly cost of ¥3,630, or approximately ¥43,000 per year. This video features a cardiologist who will explain: ✅ The mechanism of the selective medical treatment system in an easy-to-understand way ✅ The real difference between brand-name and generic drugs ✅ Why it's really okay to switch to generic heart medication ✅ Cases where special fees are waived ✅ What are authorized generics (AGs)? This video explains all of this. ───────────────────────── 📌 Timestamps for this video ───────────────────────── 0:00 Opening: Why drug prices will increase from June 2026 1:11 What is the Selective Treatment System for Long-Listed Drugs? 1:53 Specific Calculation Method (Explained Clearly) 3:00 Calculation with Actual Drugs (Xareld vs. Rivaroxaban) 4:15 Why Heart Drugs are Expensive 4:58 What are Generics (Off-Stand-Off Drugs)? 6:10 Why Generics are Cheaper = They're Not Inferior Products 7:35 Differences in Effects and Side Effects Between Original Drugs and Generics 9:05 What is the Nocebo Effect (Illness Due to Belief)? 10:29 Two Cases Where Special Fees Are Exempted 12:58 What are Authorized Generics (AGs)? 14:26 Points to Note When Choosing an AG 16:00 Conclusion: Generic heart medications are fine. ───────────────────────── 📋 Summary of this video ───────────────────────── [Changes in Selective Medical Treatment Fees] ・From October 2024: 1/4 of the difference between the original drug and the generic drug will be added as an additional co-payment. ・From June 2026: 1/2 of the difference will be added as an additional co-payment (the amount of the co-payment will double). ・This additional charge is 100% of the co-payment, not 10% to 30%. [Specific Example: Xarelde (atrial fibrillation medication)] ・Original drug: 420 yen per tablet ・Generic drug (rivaroxaba) (Original): Approximately 200 yen per tablet Additional charge: Difference of 220 yen ÷ 2 × 1.1 (consumption tax) = 121 yen/tablet 30-day supply: Approximately 3,630 yen additional cost Annually: Approximately 43,560 yen additional cost [Differences between original and generic drugs] Active ingredient: 100% the same Effects and side effects: Basically the same Differences: Additives, taste, shape, size In most cases, adverse reactions to generic drugs are due to the nocebo effect (suggestion) [Cases where special charges are waived] ① When a doctor recognizes the medical necessity (e.g., a clear allergy to an additive) ② When the pharmacy does not have the generic drug in stock 【What is an Authorized Generic (AG)?】 ・The contents are the same as the original drug, but the price is that of a generic ・It is said that more than half of all generic drugs are AGs ・Not all drugs have an AG #GenericDrugs #OriginalDrugs #GenericDrugs #SelectiveMedicalTreatmentFees #SelectiveMedicalTreatmentSystem #HeartMedication #SaveOnMedicationCosts #LongListedDrugs #2026Revision #HeartDisease #Cardiology #AtrialFibrillation #Xarelto #AuthorizedGenericDrug #AG #NoceboEffect #MedicalExpenses #Pharmacy #PrescriptionDrugs #HeartDiseaseTV 【Channel Introduction】 This channel features a practicing cardiologist who explains diseases such as "heart disease, hypertension, arrhythmia, and heart failure" from a specialist's perspective in an easy-to-understand way. We are disseminating reliable information to protect your heart health. Please support us by subscribing and liking our videos.